Bannerbild German Brest Group

GBG Research at ESMO Breast Cancer Virtual Meeting 2020

18.05.2020

GBG Research at ESMO Breast Cancer Virtual Meeting 2020

Data of several GBG research projects will be presented at the upcoming ESMO Breast Cancer Virtual Meeting 2020, which will take place from 23 to 24 May 2020.

Study: GAIN-2 Patients (pts) preference for different administration methods of trastuzumab (T) in pts with HER2+ early breast cancer (BC) treated within the GAIN-2 trial
Reinisch M, Untch M, Reimer T, et al.
ePoster #86P Date: 23-24.05.2020
Lecture Time: 12:00 - 19:30
Speakers: Mattea Reinisch

Study: BMBC Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry: Comparison of three different prognostic scores
Riecke K, Mueller V, Neunhöffer T, et al.
ePoster #149P Date: 23-24.05.2020
Lecture Time: 12:00 - 19:30
Speakers: Kerstin Riecke

Study: KATHERINE Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (T) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2+ breast cancer: Subgroup analysis from KATHERINE
Loibl S, Huang CS, Mano MS, et al.
Oral presentation #96O Date: 23.05.2020
Session: Proffered Paper session 2
Lecture Time: 16:15 - 16:30
Chairs: Giuseppe Curigliano, Sibylle Loibl
Speakers: Sibylle Loibl

Study: GeparNuevo Tumour mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo
Karn T, Denkert C, Weber K, et al.
Oral presentation #127O Date: 24.05.2020
Session: Proffered papers 3 - Best abstracts
Lecture Time: 12:45 – 14:15
Chairs: Giuseppe Curigliano, Sibylle Loibl
Speakers: Thomas Karn

News

GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440

+49 6102 7480-0 | nfGBGd